Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Bullboard Posts
Comment by PoorOpinionon Oct 18, 2018 12:46pm
79 Views
Post# 28828252

RE:RE:RE:RE:RE:RE:RE:selling

RE:RE:RE:RE:RE:RE:RE:selling
SPCEO1 wrote:
Bucknelly21 wrote: spceo don’t you feel that they could show an act of good faith for investors and get off there hands and just reassure retail?


It is certainly worth reitrerating what they have already said. Something like, "Just a reminder folks, all is well here at corporate headquarters and the company is growing nicely according to our plans". But that might not change a thing with the stock price. We just have to wait until Artisan is done selling and if they are intent to be crazy in their selling, which appears to be the case right now, the beatings will continue until morale improves!


SPCEO I thought the numbers you quoted suggested for the past Q Artisan were nett buyers (200,000 sold from one fund, 460,000 bought in another)?
Bullboard Posts